Ruiming Tang

Qingyuan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Improving Music Recommendation With Fine-Grained Content-Based Behavior Retrieval.

Improving Music Recommendation With Fine-Grained Content-Based Behavior Retrieval.

Journal: IEEE transactions on cybernetics
Published: February 04, 2026

Breaking the shields of resistance: multidimensional therapeutic strategies in the breast cancer drug resistance conundrum.

Breaking the shields of resistance: multidimensional therapeutic strategies in the breast cancer drug resistance conundrum.

Journal: International journal of surgery (London, England)
Published: July 07, 2025

Macrophage marker gene-driven prognostic models for esophageal cancer: integrating multi-omics analysis and therapeutic strategies.

Macrophage marker gene-driven prognostic models for esophageal cancer: integrating multi-omics analysis and therapeutic strategies.

Journal: 3 Biotech
Published: June 02, 2025

COL23A1 promotes tumor progression and glycolytic reprogramming in endometrial cancer via METTL14-m6A-YTHDF1 axis.

COL23A1 promotes tumor progression and glycolytic reprogramming in endometrial cancer via METTL14-m6A-YTHDF1 axis.

Journal: Cytotechnology
Published: April 18, 2025

Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer.

Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer.

Journal: Cancer discovery
Published: March 18, 2025

Suprabasin promotes gastric cancer liver metastasis via hepatic stellate cells-mediated EGF/CCL2/JAK2 intercellular signaling pathways.

Suprabasin promotes gastric cancer liver metastasis via hepatic stellate cells-mediated EGF/CCL2/JAK2 intercellular signaling pathways.

Journal: Oncogene
Published: October 11, 2024

POU6F2 promotes liver metastasis of gastric adenocarcinoma by dual mechanism of transcriptional upregulation of SNAI1 and IGF2/PI3K/AKT signaling-induced conversion of hepatic stellate cells into cancer-associated fibroblasts.

POU6F2 promotes liver metastasis of gastric adenocarcinoma by dual mechanism of transcriptional upregulation of SNAI1 and IGF2/PI3K/AKT signaling-induced conversion of hepatic stellate cells into cancer-associated fibroblasts.

Journal: British journal of cancer
Published: June 05, 2024

Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-κB activation via disrupting multiple-site ubiquitination of NEMO.

Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-κB activation via disrupting multiple-site ubiquitination of NEMO.

Journal: Cellular & molecular biology letters
Published: February 26, 2023

Extracellular vesicles-transferred SBSN drives glioma aggressiveness by activating NF-κB via ANXA1-dependent ubiquitination of NEMO.

Extracellular vesicles-transferred SBSN drives glioma aggressiveness by activating NF-κB via ANXA1-dependent ubiquitination of NEMO.

Journal: Oncogene
Published: April 26, 2022

SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling.

SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling.

Journal: British journal of cancer
Published: November 15, 2021

ACBD3 is up-regulated in gastric cancer and promotes cell cycle G1-to-S transition in an AKT-dependent manner.

ACBD3 is up-regulated in gastric cancer and promotes cell cycle G1-to-S transition in an AKT-dependent manner.

Journal: Experimental cell research
Published: March 11, 2021

miR‑30a inhibits epithelial‑mesenchymal transition and metastasis in triple‑negative breast cancer by targeting ROR1.

miR‑30a inhibits epithelial‑mesenchymal transition and metastasis in triple‑negative breast cancer by targeting ROR1.

Journal: Oncology reports
Published: November 03, 2017
Showing 1-12 of 12

Last Updated: 09/26/2026